[ECOVIR: Study of a primary care cohort in of patients with Acute Respiratory Infections in Normandy, an example of pluri-professional hospital-primary care coordination].

ECOVIR : mise en place d’une cohorte en soins primaires, un exemple de coopération pluri-professionnelle ville-hôpital.
Coordination ville-hôpital Hospital coordination Primary care Respiratory virology Soins primaires Virologie respiratoire

Journal

Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 02 07 2021
accepted: 09 02 2022
pubmed: 16 3 2022
medline: 24 5 2022
entrez: 15 3 2022
Statut: ppublish

Résumé

Acute Respiratory Infections (ARI) need be better understood and more effectively treated, especially insofar as they are of pivotal importance in public health, particularly during a crisis such as the SARS-CoV2 pandemic. The prospective, multicentric cohort study of viral codetections in respiratory samples study known as ECOVIR was conducted in Normandy, France during two winters (2018-2019, 2019-2020). The objective of the project was to create a biobank of respiratory tract samples from patients consulting their general practitioner (GP) for ARI symptoms. ECOVIR involved 36 GP investigators (GPI), from 8 health care centers throughout Normandy. Six hundred and eighty-five patients with ARI symptoms were included; naso-pharyngeal samples were taken by the GPIs and subsequently analyzed in virology laboratories for the purposes of viral codetection. The median of inclusions was 16 patients for each of the 31 actively participating GPIs over the two winters (CI25-75% [4.75; 27]). By D7, 92% of the patients contacted had responded to our call for participation, enabling us to obtain clinical, environmental and socio-demographic data. Through this study, we created an original functional network, thereby establishing a viable link between research and primary care, which is generally underrepresented in research protocols, even though it constitutes the cornerstone of the French health care system, especially during this prolonged period of sanitary crisis.

Identifiants

pubmed: 35289288
pii: S0761-8425(22)00131-0
doi: 10.1016/j.rmr.2022.02.060
pmc: PMC8916614
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

334-343

Informations de copyright

Copyright © 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Références

N Engl J Med. 2015 Feb 26;372(9):835-45
pubmed: 25714161
J Infect Dis. 2014 Dec 1;210(11):1792-9
pubmed: 24907381
Clin Microbiol Infect. 2018 Nov;24(11):1158-1163
pubmed: 29447989
Pediatrics. 2015 Apr;135(4):607-16
pubmed: 25733757
Rev Mal Respir. 2017 May;34(5):525-534
pubmed: 27919604
Respirology. 2010 May;15(4):691-9
pubmed: 20409023
Respir Med. 2014 Jan;108(1):218-23
pubmed: 24345311
N Engl J Med. 2015 Jul 30;373(5):415-27
pubmed: 26172429
Rev Mal Respir. 2017 Feb;34(2):134-146
pubmed: 28262277

Auteurs

H Petat (H)

Groupe de recherche sur l'adaptation microbienne (GRAM 2.0), Normandie université, UNICAEN, UNIROUEN, EA2656, 14033 Caen, France; Laboratoire de virologie, centre hospitalo-universitaire, 14033 Caen, France; Département de pédiatrie médicale, centre hospitalier universitaire de Rouen, EA2656 université de Normandie, UNIRouen, 76000 Rouen, France. Electronic address: hortense.petat@univ-rouen.fr.

M Schuers (M)

Normandie université, UFR Santé Rouen, département de médecine générale, 76000 Rouen, France; Inserm, U1142, laboratoire d'informatique médicale et d'ingénierie des connaissances en e-Santé, LIMICS, Sorbonne université, Paris, France.

A Rabiaza (A)

Normandie université, UNICAEN, UFR Santé, département de médecine générale, 14000 Caen, France.

C Marguet (C)

Groupe de recherche sur l'adaptation microbienne (GRAM 2.0), Normandie université, UNICAEN, UNIROUEN, EA2656, 14033 Caen, France; Département de pédiatrie médicale, centre hospitalier universitaire de Rouen, EA2656 université de Normandie, UNIRouen, 76000 Rouen, France.

L Pellerin (L)

Normandie université, UFR Santé Rouen, département de médecine générale, 76000 Rouen, France.

F Le Bas (F)

Normandie université, UNICAEN, UFR Santé, département de médecine générale, 14000 Caen, France.

X Humbert (X)

Normandie université, UNICAEN, UFR Santé, département de médecine générale, 14000 Caen, France.

S Corbet (S)

Laboratoire de virologie, centre hospitalo-universitaire, 14033 Caen, France; Département de pédiatrie médicale, centre hospitalier universitaire de Rouen, EA2656 université de Normandie, UNIRouen, 76000 Rouen, France.

B Deseille (B)

Normandie université, UFR Santé Rouen, département de médecine générale, 76000 Rouen, France.

L Gosse (L)

Normandie université, UFR Santé Rouen, département de médecine générale, 76000 Rouen, France.

P-A Lambert (PA)

Normandie université, UFR Santé Rouen, département de médecine générale, 76000 Rouen, France.

T Poupon (T)

Normandie université, UFR Santé Rouen, département de médecine générale, 76000 Rouen, France.

E Vervisch (E)

Normandie université, UFR Santé Rouen, département de médecine générale, 76000 Rouen, France.

R Morello (R)

CHU de Caen Normandie, Normandie université, UNICAEN, unité de biostatistique et recherche clinique, 14000 Caen, France.

F Chaillot (F)

CHU de Caen Normandie, unité de recherche clinique, 14000 Caen, France.

M Ecovir (M)

Normandie université, UFR Santé Rouen, département de médecine générale, 76000 Rouen, France.

A Vabret (A)

Groupe de recherche sur l'adaptation microbienne (GRAM 2.0), Normandie université, UNICAEN, UNIROUEN, EA2656, 14033 Caen, France; Laboratoire de virologie, centre hospitalo-universitaire, 14033 Caen, France.

M Le Gouil (M)

Groupe de recherche sur l'adaptation microbienne (GRAM 2.0), Normandie université, UNICAEN, UNIROUEN, EA2656, 14033 Caen, France; Laboratoire de virologie, centre hospitalo-universitaire, 14033 Caen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH